Ardent Health Faces Class Action Lawsuit
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Globenewswire
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Ardent Health, alleging securities fraud and unlawful business practices, with investors needing to apply as Lead Plaintiff by March 9, 2026.
- Significant Revenue Decline: Ardent reported a $43 million decrease in Q3 2025 revenue, primarily due to revised assessments of accounts receivable collectability following the transition to a new revenue accounting system, impacting the company's financial stability.
- EBITDA Guidance Cut: The company lowered its 2025 EBITDA guidance to between $530 million and $555 million, a reduction of approximately 9.6% from the previous range of $575 million to $625 million, reflecting persistent industry-wide cost pressures and payer denials.
- Stock Price Plunge: Following the negative news, Ardent's stock price fell by $4.75, or 33.81%, closing at $9.30 per share on November 13, 2025, indicating a pessimistic outlook from the market regarding the company's future prospects.
Analyst Views on ARDT
Wall Street analysts forecast ARDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARDT is 13.73 USD with a low forecast of 10.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 8.460
Low
10.00
Averages
13.73
High
17.00
Current: 8.460
Low
10.00
Averages
13.73
High
17.00
About ARDT
Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
